Know Cancer

or
forgot password

Magnetic Resonance Imaging and Spectroscopy of the Prostate


N/A
18 Years
N/A
Not Enrolling
Male
Prostate Cancer

Thank you

Trial Information

Magnetic Resonance Imaging and Spectroscopy of the Prostate


Inclusion Criteria:



- prostate cancer patients willing to undergo a MRI and MRSI exam

Exclusion Criteria:

- patients with prostate cancer and bone or lymph node metastasis

- patients who can not have an MRI exam

Type of Study:

Observational

Study Design:

Observational Model: Cohort, Time Perspective: Prospective

Outcome Measure:

Determine added value in combining MRSI and MRI in prostate cancer treatment

Outcome Time Frame:

3 hours

Safety Issue:

No

Principal Investigator

Hedvig Hricak, MD

Investigator Role:

Principal Investigator

Investigator Affiliation:

Memorial Sloan-Kettering Cancer Center

Authority:

United States: Food and Drug Administration

Study ID:

00-136

NCT ID:

NCT00590993

Start Date:

December 2000

Completion Date:

February 2013

Related Keywords:

  • Prostate Cancer
  • MRSI
  • MRI
  • Prostate Cancer
  • Prostatic Neoplasms

Name

Location

Memorial Sloan Kettering Cancer CenterNew York, New York  10021